ARTICLE | Management Tracks
Hartley to succeed Winkler as OnKure’s CSO
Plus: Patterson joins Zymeworks and updates from Stuart Therapeutics and JLABS
July 27, 2024 12:47 AM UTC
OnKure Inc. hired Dylan Hartley to succeed CSO James Winkler, who will become an adviser and consultant to the company. Hartley was VP, head of research at Pfizer Inc. (NYSE:PFE). OnKure is developing tumor-agnostic cancer drugs.
Zymeworks Inc. (NASDAQ:ZYME) hired Leone Patterson as chief business and financial officer, effective Sept. 1. Patterson was chief financial and business officer at Tenaya Therapeutics Inc. (NASDAQ:TNYA)...